✦ LIBER ✦

Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial

✍ Scribed by Jersey Chen; Chunxue Shi; Elizabeth M. Mahoney; Elizabeth Schneider Dunn; Stéphane Rinfret; J. Jaime Caro; Judith O'Brien; Wissam El-Hadi; Deepak L. Bhatt; Eric J. Topol; David J. Cohen

Book ID: 116362863
Publisher: Pulsus Group Inc
Year: 2011
Tongue: English
Weight: 751 KB
Volume: 27
Category: Article
ISSN: 0828-282X
DOI: 10.1016/j.cjca.2010.12.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Clopidogrel plus A

Cost-Effectiveness of Clopidogrel plus Aspirin versus Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial

✍ Jersey Chen; Deepak L. Bhatt; Elizabeth Schneider Dunn; Chunxue Shi; J. Jaime Ca 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A comparison of aspirin and clopidogrel

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding

✍ Fei-Yuan Hsiao; Yi-Wen Tsai; Weng-Foung Huang; Yu-Wen Wen; Pei-Fen Chen; Po-Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Registry of Lipid Control and the Use of

Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods

✍ Yin, Wei-Hsian; Wu, Chau-Chung; Chen, Jaw-Wen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Effect of Amlodipine + Candesartan on Ca

Effect of Amlodipine + Candesartan on Cardiovascular Events in Hypertensive Patients With Coronary Artery Disease (from The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Study)

✍ Junichi Yamaguchi; Nobuhisa Hagiwara; Hiroshi Ogawa; Ryo Koyanagi; Hiroshi Kasan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1001 KB

Trial suggests long term trapidil reduce

Trial suggests long term trapidil reduces cardiovascular events and improves prognosis in coronary artery disease: Abstracted from: Hirayama A, Kodama K, Yui Y et al. Effect of trapidil on cardiovascular events in patients with coronary artery disease (Results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]). Am J Cardiol 2003; 92: 789–93

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 135 KB